These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
264 related items for PubMed ID: 25205367
21. Enhancement of the behavioral response to apomorphine administration following repeated treatment in the 6-hydroxydopamine-lesioned rat is temporally correlated with a rise in striatal preproenkephalin-B, but not preproenkephalin-A, gene expression. Duty S, Brotchie JM. Exp Neurol; 1997 Apr; 144(2):423-32. PubMed ID: 9168843 [Abstract] [Full Text] [Related]
22. Nicotine induces sensitization of turning behavior in 6-hydroxydopamine lesioned rats. Gregório ML, Wietzikoski EC, Ferro MM, Silveira JL, Vital MA, Da Cunha C. Neurotox Res; 2009 May; 15(4):359-66. PubMed ID: 19384569 [Abstract] [Full Text] [Related]
23. The 6-OHDA mouse model of Parkinson's disease - Terminal striatal lesions provide a superior measure of neuronal loss and replacement than median forebrain bundle lesions. Bagga V, Dunnett SB, Fricker RA. Behav Brain Res; 2015 Jul 15; 288():107-17. PubMed ID: 25841616 [Abstract] [Full Text] [Related]
24. EEG modifications in the cortex and striatum after dopaminergic priming in the 6-hydroxydopamine rat model of Parkinson's disease. Vorobyov VV, Schibaev NV, Morelli M, Carta AR. Brain Res; 2003 May 16; 972(1-2):177-85. PubMed ID: 12711091 [Abstract] [Full Text] [Related]
25. Relation between microPET imaging and rotational behavior in a parkinsonian rat model induced by medial forebrain bundle axotomy. Liu L, Zhang W, Gong X, Liang X, Wang X. Behav Brain Res; 2014 May 15; 265():148-54. PubMed ID: 24548854 [Abstract] [Full Text] [Related]
26. Pituitary adenylate cyclase activating polypeptide protects dopaminergic neurons and improves behavioral deficits in a rat model of Parkinson's disease. Reglodi D, Lubics A, Tamás A, Szalontay L, Lengvári I. Behav Brain Res; 2004 May 05; 151(1-2):303-12. PubMed ID: 15084446 [Abstract] [Full Text] [Related]
27. Involvement of brain endogenous histamine in the degeneration of dopaminergic neurons in 6-hydroxydopamine-lesioned rats. Liu CQ, Chen Z, Liu FX, Hu DN, Luo JH. Neuropharmacology; 2007 Dec 05; 53(7):832-41. PubMed ID: 17919665 [Abstract] [Full Text] [Related]
28. Electroacupuncture Alleviates Motor Symptoms and Up-Regulates Vesicular Glutamatergic Transporter 1 Expression in the Subthalamic Nucleus in a Unilateral 6-Hydroxydopamine-Lesioned Hemi-Parkinsonian Rat Model. Wang Y, Wang Y, Liu J, Wang X. Neurosci Bull; 2018 Jun 05; 34(3):476-484. PubMed ID: 29508251 [Abstract] [Full Text] [Related]
29. Increased tyrosine hydroxylase expression accompanied by glial changes within the non-lesioned hemisphere in the 6-hydroxydopamine model of Parkinson's disease. Schlachetzki JC, Marxreiter F, Regensburger M, Kulinich A, Winner B, Winkler J. Restor Neurol Neurosci; 2014 Jun 05; 32(4):447-62. PubMed ID: 24604006 [Abstract] [Full Text] [Related]
30. Effects of pallidotomy on motor symptoms in an animal model of Parkinson's disease. Henderson J, Doherty K, Allbutt H, Billing R. Behav Brain Res; 2006 Apr 25; 169(1):29-38. PubMed ID: 16406102 [Abstract] [Full Text] [Related]
31. Behavioral sensitization to different dopamine agonists in a parkinsonian rodent model of drug-induced dyskinesias. Delfino MA, Stefano AV, Ferrario JE, Taravini IR, Murer MG, Gershanik OS. Behav Brain Res; 2004 Jul 09; 152(2):297-306. PubMed ID: 15196797 [Abstract] [Full Text] [Related]
32. Behavioural effects of a selective NMDA NR1A/2B receptor antagonist in rats with unilateral 6-OHDA+parafascicular lesions. Truong L, Allbutt HN, Coster MJ, Kassiou M, Henderson JM. Brain Res Bull; 2009 Feb 16; 78(2-3):91-6. PubMed ID: 19007866 [Abstract] [Full Text] [Related]
33. Sexually dimorphic postural adjustments during vertical behaviour are altered in a unilateral 6-OHDA rat model of Parkinson's disease. Field EF, Metz GA, Pellis SM, Whishaw IQ. Behav Brain Res; 2006 Nov 01; 174(1):39-48. PubMed ID: 16930735 [Abstract] [Full Text] [Related]
34. Rats with unilateral median forebrain bundle, but not striatal or nigral, lesions by the neurotoxins MPP+ or rotenone display differential sensitivity to amphetamine and apomorphine. Sindhu KM, Banerjee R, Senthilkumar KS, Saravanan KS, Raju BC, Rao JM, Mohanakumar KP. Pharmacol Biochem Behav; 2006 Jun 01; 84(2):321-9. PubMed ID: 16820197 [Abstract] [Full Text] [Related]
35. Increased progenitor cell proliferation and astrogenesis in the partial progressive 6-hydroxydopamine model of Parkinson's disease. Aponso PM, Faull RL, Connor B. Neuroscience; 2008 Feb 19; 151(4):1142-53. PubMed ID: 18201835 [Abstract] [Full Text] [Related]
36. Neurorescue effects of VEGF on a rat model of Parkinson's disease. Yasuhara T, Shingo T, Muraoka K, Kameda M, Agari T, Wen Ji Y, Hayase H, Hamada H, Borlongan CV, Date I. Brain Res; 2005 Aug 16; 1053(1-2):10-8. PubMed ID: 16045899 [Abstract] [Full Text] [Related]
37. Behavioral and anatomical effects of quinolinic acid in the striatum of the hemiparkinsonian rat. Olds ME, Jacques DB, Kopyov O. Synapse; 2005 Jan 16; 55(1):26-36. PubMed ID: 15499610 [Abstract] [Full Text] [Related]
39. Neuronal firing activity and gene expression changes in the subthalamic nucleus after transplantation of dopamine neurons in hemiparkinsonian rats. Rumpel R, Alam M, Klein A, Özer M, Wesemann M, Jin X, Krauss JK, Schwabe K, Ratzka A, Grothe C. Neurobiol Dis; 2013 Nov 16; 59():230-43. PubMed ID: 23938762 [Abstract] [Full Text] [Related]
40. Forced exercise before or after induction of 6-OHDA-mediated nigrostriatal insult does not mitigate behavioral asymmetry in a hemiparkinsonian rat model. Landers MR, Kinney JW, van Breukelen F. Brain Res; 2014 Jan 16; 1543():263-70. PubMed ID: 24239657 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]